Apolipoprotein e polymorphism in hemodialyzed patients and healthy controls

Biochemical Genetics

Volumn 47, Issue 9-10, 2009, Pages 688-693

  Hubacek, Jaroslav A ^a,b,c   Bloudickova, Silvie ^a   Kubinova, Ruzena ^d   Pikhart, Hynek ^e   Viklicky, Ondrej ^a   Bobak, Martin ^e  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Cardiovascular Research Center   (Czech Republic)

^d NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apolipoprotein E; End stage renal disease; Polymorphism

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CZECH REPUBLIC; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE;

AGED; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; GENOTYPE; HEALTH; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; POLYMORPHISM, GENETIC; RENAL DIALYSIS;

EID: 70349626805     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-009-9266-y     Document Type: Article

References (21)

1. H Arikan M Koc H Sari S Tuglular C Ozener E Akoglu 2007 Association between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients Ren Fail 29 713 719 17763167 10.1080/08860220701460129 1:CAS:528:DC%2BD2sXps1GksLs%3D (Pubitemid 47346992)
2. G Chen L Paka Y Kako P Singhal W Duan S Pillarisetti 2001 A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion J Biol Chem 276 49142 49147 11579084 10.1074/jbc.M104879200 1:CAS:528:DC%2BD38Xktlemtg%3D%3D
3. J Davignon RE Gregg CF Sing 1988 Apolipoprotein E polymorphism and atherosclerosis Atherosclerosis 8 1 21 1:CAS:528:DyaL1cXht12gu7o%3D
4. G Feussner S Wey J Bommer D Deppermann P Grützmacher R Ziegler 1992 Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis Hum Genet 88 307 312 1733833 10.1007/BF00197265 1:STN:280:DyaK387ivVyqtA%3D%3D
5. LU Gerdes IC Klausen I Sihn O Faergeman 1992 Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study population around the world Genet Epidemiol 9 155 167 1381696 10.1002/gepi.1370090302 1:STN:280:DyaK38zpsVGjtQ%3D%3D
6. ML Gross K Amann 2004 Progression of renal disease: new insights into risk factors and pathomechanisms Curr Opin Nephrol Hypertens 13 307 312 15073489 10.1097/00041552-200405000-00007 (Pubitemid 38582303)
7. G Güz F Nurhan Ozdemir S Sezer I Işiklar Z Arat M Turan M Haberal 2000 Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysed patients Am J Kidney Dis 36 826 836 11007687 10.1053/ajkd.2000.17682
8. JE Hixson DT Vernier 1990 Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 31 545 548 2341813 1:CAS:528:DyaK3cXitlWqu7o%3D
9. K Horita M Eto I Makino 1994 Apolipoprotein E, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus Atherosclerosis 107 203 211 7980694 10.1016/0021-9150(94)90021-3 1:CAS:528:DyaK2cXltlWnsLk%3D (Pubitemid 24206859)
10. JA Hubacek J Pitha P Stávek R Poledne 2000 Variable expression of hypercholesterolemia in apolipoprotein E2*(Arg136 → Cys) heterozygotes Physiol Res 49 307 314 11043917 1:CAS:528:DC%2BD3cXmsV2ksbo%3D
11. JA Hubacek S Bloudíčková R Bohuslavová P Táborský V Polakovic M Sazamová E Svítilová J Vlasák I Sojková M Ryba P Knetl M Ullrych R Drahozal V Pavuková B Pavlíková D Fischlová M Mokrejsová H Chmelícková E Pauchová P Vyskocil Z Ný dlová J Kopenec P Fixa J Hajný P Bubenícek P Syrovátka J Zahálková S Surel Z Hobzek A Hrubý J Suchanová S Vanková J Brabcová O Viklický MIA Group 2007 Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients Clin Chem Lab Med 45 1121 1123 17635077 10.1515/CCLM.2007.141 1:CAS:528:DC%2BD2sXhtFKjt7vK (Pubitemid 47396258)
12. M Leblanc JA Kellum RT Gibney W Lieberthal J Tumlin R Mehta 2005 Risk factors for acute renal failure: inherent and modifiable risks Curr Opin Crit Care 11 533 536 16292055 10.1097/01.ccx.0000183666.54717.3d (Pubitemid 41697323)
13. E Liberopoulos K Siamopoulos M Elisaf 2004 Apolipoprotein E and renal disease Am J Kidney Dis 43 223 233 14750087 10.1053/j.ajkd.2003.10.013 1:CAS:528:DC%2BD2cXhsl2msLw%3D (Pubitemid 38146320)
14. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acid Res 16 1215 3344216 10.1093/nar/16.3.1215 1:CAS:528:DyaL1cXhsVKlsrs%3D
15. S Moeller S Gioberge G Brown 2002 ESRD patients in 2001: global overview of patients, treatment modalities and development trends Nephrol Dial Transplant 17 2071 2076 12454213 10.1093/ndt/17.12.2071
16. L Nordfors B Lindholm P Stenvinkel 2005 End-stage renal disease-not an equal opportunity disease: the role of genetic polymorphisms J Intern Med 258 1 12 15953127 10.1111/j.1365-2796.2005.01516.x 1:CAS:528:DC%2BD2MXms12htbo%3D (Pubitemid 40904927)
17. H Oda N Yorioka C Ueda S Kushikata M Yamakido 1999 Apolipoprotein E polymorphism and renal disease Kidney Int Suppl 71 S25 S27 10412731 10.1046/j.1523-1755.1999.07107.x 1:STN:280:DyaK1MzktFansA%3D%3D
18. A Peasey M Bobak R Kubinova S Malyutina A Pajak A Tamosiunas H Pikhart A Nicholson M Marmot 2006 Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study BMC Public Health 6 255 17049075 10.1186/1471-2458-6-255 (Pubitemid 44668771)
19. R Pecoits-Filho B Lindholm P Stenvinkel 2002 The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter Nephrol Dial Transplant 17 Suppl 11 28 31 12386254 1:CAS:528:DC%2BD38Xptlektrg%3D
20. L Roussos U Ekström PN Ehle B Oqvist CH Floren 2004 Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden Scand J Urol Nephrol 38 504 510 15841787 10.1080/00365590410033443 1:CAS:528: DC%2BD2MXhtVejsLw%3D (Pubitemid 39665418)
21. H Svobodova F Kucera T Stulc M Vrablík B Amartuvshin Ts Altannavch R Ceska 2007 Apolipoprotein E gene polymorphism in the Mongolian population Folia Biol (Praha) 53 138 142 1:STN:280:DC%2BD2svoslOkuw%3D%3D